ArticleslgStudy

chemistry

NS-11821

NS-11821 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand NS-11821 rather than just read about it. In short: NS-11821, or NS11821 is a GABAA receptor positive allosteric modulator and nonbenzodiazepine which was under development for the treatment of anxiety disorders and CNS disorders but was never marketed. It is taken orally.

Key takeaways

  • NS-11821 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect NS-11821 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of NS-11821 from memory before moving on to harder problems.

Reference excerpt

NS-11821, or NS11821 is a GABAA receptor positive allosteric modulator and nonbenzodiazepine which was under development for the treatment of anxiety disorders and CNS disorders but was never marketed. It is taken orally. The drug is a subunit-selective partial positive allosteric modulator of the GABAA receptor. More specifically, it shows affinity (Ki) values of 1.6 nM at α1, 9.7 nM at α2, 3.8 nM at α3, and 2.5 nM at α5, whereas it shows EC50Tooltip half-maximal effective concentration (EmaxTooltip maximal efficacy) values of ND (4%) at α1, 59 nM (17%) at α2, 73 nM (40%) at α3, and 44 nM (41%) at α5. Based on animal studies, this is expected to translate into a profile of anxiolytic effects with low propensity for sedation. Clinical findings of NS-11821 in humans have been described. NS-11821 was under development by NeuroSearch. It reached phase 1 clinical trials for both anxiety disorders and CNS disorders prior to the discontinuation of its development in 2017. The chemical structure of NS-11821 does not yet appear to have been disclosed.

See also List of investigational anxiety disorder drugs

References

Worked examples

Example 1 — a first encounter with NS-11821

Start with the simplest possible case. Write down what NS-11821 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to NS-11821 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about NS-11821 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of NS-11821

In research
NS-11821 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses NS-11821 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
NS-11821 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Abandoned drugs, Drugs not assigned an ATC code, Drugs with undisclosed chemical structures, so understanding it makes those chapters shorter.
In everyday life
Look for NS-11821 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “NS-11821” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study NS-11821 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what NS-11821 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain NS-11821 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is NS-11821 in simple terms?

NS-11821, or NS11821 is a GABAA receptor positive allosteric modulator and nonbenzodiazepine which was under development for the treatment of anxiety disorders and CNS disorders but was never marketed. It is taken orally.

Why does NS-11821 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study NS-11821?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on NS-11821.

Tags

  • Abandoned drugs
  • Drugs not assigned an ATC code
  • Drugs with undisclosed chemical structures
  • Experimental anxiolytics
  • GABAA receptor positive allosteric modulators
  • Nonbenzodiazepines

Keep exploring